Clinical ink secures new co-control investment from Ardan Equity and GI Partners to enhance growth.
Round Type
Private Equity
Winston-SalemOtherDescription
Clinical ink announced on October 19, 2026, that Ardan Equity and GI Partners have made new equity investments, allowing them to share control of the company. The management team, led by CEO Jonathan Goldman, looks forward to collaborating with both firms to scale the business globally and explore further opportunities in clinical research and care.
Who to call at Clinical Ink, Inc., and when
A new round usually means Clinical Ink, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Clinical Ink, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Clinical Ink, Inc., from your own LinkedIn network
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Clinical Ink, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Clinical Ink, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.